제10회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 블록포스트 가이드포스트 fn아이포커스 파이낸셜뉴스재팬 fnMICE fn이노에듀 fn투어


지난행사목록

본문

 

 

 

Introduction  

 

 

The Seoul International New Pharmaceuticals Forum, which took its first step in 2009, 

celebrates its 10th anniversary this year.

  

The Seoul International New Pharmaceuticals Forum, which has been launched under the theme of "Beyond the Barrier of the Global New Pharmaceuticals" at the first Forum, 

has been dealing the major issues emerging in the development of new pharmaceuticals 

every year, such as △ Changes and challenges in the new pharmaceuticals development 

paradigm △ A new 10-year for Pharmaceutical and Bio fields △ Global innovative new 

pharmaceuticals - Customized medicines △ Creative economy era and R & D for new 

pharmaceuticals △ Creative paradigm of pharmaceutical industry: Establishment of 

virtuous cycle structure for the development of new pharmaceuticals 

△ Research of new diseases due to bacteria and virus, development of therapeutic 

medicines and vaccines to control them △ Pharmaceutical industry, prior occupation of 

new market for therapeutic medicines to control rare diseases as a new growth engine and 

△ Development of new pharmaceuticals using medical big data.

  

In the meantime, the pharmaceutical industry has undergone drastic changes. In particular, 

domestic pharmaceutical companies have been making continuous efforts to develop new pharmaceuticals. As a result, exports of complete products of  pharmaceuticals surpassed 

$ 2 billion for the first time last year. This was achieved in four years after the export volume 

exceeded $ 1 billion in 2013. In addition, the exports of bio-pharmaceuticals, which have just 

entered the market, recorded over $1 billion in 2016.

  

Of course, there was a sharp decline in sales in 2010 due to the implementation of 

the bilateral punishment against rebate payment. However, large domestic pharmaceutical 

companies, including Hanmi Pharm. Company, have concluded contracts for technology 

exportation with global Big-Pharma. companies one after another, enhancing the possibility of 

new pharmaceutical development.

  

In response to this trend,  the Government, at the Pharmaceutical Industry Promotion Committee 

early this year, has disclosed that it will provide the implementation plan for detailed projects for the 

development of new pharmaceuticals using information and communication technology (ICT) and 

the development of next-generation bio-pharmaceuticals such as the medicines for l dementia and 

gene therapy in order take lead in the 4th industrial revolution.

  

At the Seoul International New Pharmaceuticals Forum this year, you can find out how Open 

Innovation, a  new conception emerging at the backdrop of the 4th industrial revolution, shall be 

applied to the development of new pharmaceuticals. Currently, there are cases where the 

results have reached clinical level through the inter-country projects with Duke University and 

University of Singapore.

  

In addition, IBM will present a review on how you can use AI, the core technology of the 4th 

industrial revolution, in  R & D for new pharmaceuticals development. Further, you will be 

furnished with updated information about CAR-T of Novartis, the personally customized 

cell therapy medicine, that has emerged as a new issue recently, as well as  AstraZeneca's 5R 

framework aimed to improve the productivity of new pharmaceuticals development researches.

  

The 10th Seoul International New Pharmaceuticals Forum will have the opportunity to examine 

how new technologies developing in the path of 4th industrial revolution, can help develop new 

pharmaceuticals through its application to such development projects.

 

 

 

Overview 

 

 

Title : The 10h Seoul International New Pharmaceuticals Forum

  

Theme : New Drug Development, Convergence with New Technology

 

Date : June 21st, 2018(Thu) / 09:00 ~ 16:00

 

Venue : Grand Ballroom, The Westin Chosun Hotel, Seoul

 

Host : The Financial News, Korea Research Institute of Chemical Technology

 

Supporters : Ministry of Health and Welfare, Ministry of Science and ICT, 

                        National Institute of Food and Drug Safety Evaluation,

                        Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 

                        Korea Biotechnology Industry Organization,

                        Korea Research-based Pharmaceutical Industry Association


Inquiry : Seoul International New Pharmaceuticals Forum

                Tel. 02-6965-0014 / Mail. iamkhs@fnnews.com

첨부파일

서울특별시 서초구 강남대로 315, 파이낸셜뉴스빌딩 9층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnmice.com
Copyright (c) fnMICE. All rights reserved.